CRP and Cowden disease: Clinical remission has been induced in 60–86% of patients, accompanied by improvement in biomarkers of inflammation C‐reactive protein (CRP) and fecal calprotectin (FC).2, 15 Pediatric data also show that EEN achieves mucosal healing and has comparable efficacy to antitumor necrosis alpha therapy in children with CD; however, there are no comparative studies in adults.16, 17